These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9251946)

  • 1. Islet amyloid polypeptide (amylin) does not seem to be directly involved in the development of gestational diabetes mellitus.
    Grigorakis SI; Alevizaki M; Rapti E; Anastasiou E; Alevizaki CC; Souvatzoglou A
    Gynecol Obstet Invest; 1997; 44(1):6-10. PubMed ID: 9251946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postpartum evaluation of amylin secretion in gestational diabetes mellitus].
    Kinalski M; Sledziewski A; Telejko B; Mironczuk K; Kretowski A; Kinalska I
    Med Wieku Rozwoj; 2002; 6(1):75-80. PubMed ID: 12177515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
    Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of insulin treatment on islet amyloid polypeptide (amylin) and insulin gene expression in streptozotocin-induced diabetes in rats.
    Mulder H; Ahrén B; Sundler F
    J Endocrinol; 1997 Mar; 152(3):495-501. PubMed ID: 9071971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.
    Sanke T; Hanabusa T; Nakano Y; Oki C; Okai K; Nishimura S; Kondo M; Nanjo K
    Diabetologia; 1991 Feb; 34(2):129-32. PubMed ID: 2065848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes.
    Mulder H; Gebre-Medhin S; Betsholtz C; Sundler F; Ahrén B
    Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E684-91. PubMed ID: 10751203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
    O'Brien TD; Butler PC; Westermark P; Johnson KH
    Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus.
    Guardado-Mendoza R; Chávez AO; Jiménez-Ceja LM; Hansis-Diarte A; DeFronzo RA; Folli F; Tripathy D
    Acta Diabetol; 2017 Jan; 54(1):53-61. PubMed ID: 27624579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism.
    Valdermarsson S; Leckström A; Westermark P; Bergenfelz A
    Eur J Endocrinol; 1996 Mar; 134(3):320-5. PubMed ID: 8616529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).
    Gebre-Medhin S; Mulder H; Pekny M; Westermark G; Törnell J; Westermark P; Sundler F; Ahrén B; Betsholtz C
    Biochem Biophys Res Commun; 1998 Sep; 250(2):271-7. PubMed ID: 9753619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in cats.
    Johnson KH; O'Brien TD; Jordan K; Betsholtz C; Westermark P
    Biochem Biophys Res Commun; 1990 Mar; 167(2):507-13. PubMed ID: 2182015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-partum evaluation of amylin in lean patients with gestational diabetes mellitus.
    Kinalski M; Sledziewski A; Telejko B; Straczkowski M; Kretowski A; Kinalska I
    Acta Diabetol; 2004 Mar; 41(1):1-4. PubMed ID: 15057546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
    Permert J; Larsson J; Westermark GT; Herrington MK; Christmanson L; Pour PM; Westermark P; Adrian TE
    N Engl J Med; 1994 Feb; 330(5):313-8. PubMed ID: 8277951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myostatin in the placentae of pregnancies complicated with gestational diabetes mellitus.
    Peiris HN; Lappas M; Georgiou HM; Vaswani K; Salomon C; Rice GE; Mitchell MD
    Placenta; 2015 Jan; 36(1):1-6. PubMed ID: 25443639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose tolerant, and diabetic cats.
    Ma Z; Westermark GT; Johnson KH; O'Brien TD; Westermark P
    Amyloid; 1998 Dec; 5(4):255-61. PubMed ID: 10036583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
    Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
    Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.
    Ludvik B; Clodi M; Kautzky-Willer A; Schuller M; Graf H; Hartter E; Pacini G; Prager R
    J Clin Invest; 1994 Nov; 94(5):2045-50. PubMed ID: 7962550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.